BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35766982)

  • 21. Rationalization of paclitaxel insensitivity of yeast β-tubulin and human βIII-tubulin isotype using principal component analysis.
    Das L; Bhattacharya B; Basu G
    BMC Res Notes; 2012 Aug; 5():395. PubMed ID: 22849332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tubulin isotype substitution revealed that isotype combination modulates microtubule dynamics in
    Honda Y; Tsuchiya K; Sumiyoshi E; Haruta N; Sugimoto A
    J Cell Sci; 2017 May; 130(9):1652-1661. PubMed ID: 28302908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrostatic contributions to colchicine binding within tubulin isotypes.
    Huzil JT; Barakat K; Tuszynski JA
    Electromagn Biol Med; 2009; 28(4):355-64. PubMed ID: 20017626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible Roles of Specific Amino Acids in β-Tubulin Isotypes in the Growth and Maintenance of Neurons: Novel Insights From Cephalopod Mollusks.
    Ludueña RF
    Front Mol Neurosci; 2022; 15():838393. PubMed ID: 35493322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of halichondrin B and eribulin with tubulin.
    Bai R; Nguyen TL; Burnett JC; Atasoylu O; Munro MH; Pettit GR; Smith AB; Gussio R; Hamel E
    J Chem Inf Model; 2011 Jun; 51(6):1393-404. PubMed ID: 21539396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eribulin disrupts EB1-microtubule plus-tip complex formation.
    O'Rourke B; Yang CP; Sharp D; Horwitz SB
    Cell Cycle; 2014; 13(20):3218-21. PubMed ID: 25485501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. βII-tubulin and βIII-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells.
    Kanakkanthara A; Northcote PT; Miller JH
    Mol Cancer Ther; 2012 Feb; 11(2):393-404. PubMed ID: 22180309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular insight of isotypes specific β-tubulin interaction of tubulin heterodimer with noscapinoids.
    Santoshi S; Naik PK
    J Comput Aided Mol Des; 2014 Jul; 28(7):751-63. PubMed ID: 24916062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A label-free mass spectrometry method for relative quantitation of β-tubulin isotype expression in human tumor tissue.
    Miller LM; Huang Yang CP; Xiao H; Isaac S; Sève P; Dumontet C; Band Horwitz S; Hogue Angeletti R
    Proteomics Clin Appl; 2012 Oct; 6(9-10):502-6. PubMed ID: 22996942
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Pallante L; Rocca A; Klejborowska G; Huczynski A; Grasso G; Tuszynski JA; Deriu MA
    Front Chem; 2020; 8():108. PubMed ID: 32154219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of a monoclonal antibody specific for the class I isotype of beta-tubulin: the beta isotypes of tubulin differ in their cellular distributions within human tissues.
    Roach MC; Boucher VL; Walss C; Ravdin PM; Ludueña RF
    Cell Motil Cytoskeleton; 1998; 39(4):273-85. PubMed ID: 9580378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of human betaV-tubulin expression in epithelial cancer cell lines by tubulin proteomics.
    Verdier-Pinard P; Shahabi S; Wang F; Burd B; Xiao H; Goldberg GL; Orr GA; Horwitz SB
    Biochemistry; 2005 Dec; 44(48):15858-70. PubMed ID: 16313188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of an intermediate taxol binding site within microtubule nanopores and a mechanism for tubulin isotype binding selectivity.
    Freedman H; Huzil JT; Luchko T; Ludueña RF; Tuszynski JA
    J Chem Inf Model; 2009 Feb; 49(2):424-36. PubMed ID: 19434843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Class III
    Yahiro K; Matsumoto Y; Fukushi JI; Kawaguchi KI; Endo M; Setsu N; IIda K; Fukushima S; Nakagawa M; Kimura A; Oda Y; Nakashima Y
    Anal Cell Pathol (Amst); 2018; 2018():8987568. PubMed ID: 30034996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The roles of cys124 and ser239 in the functional properties of human betaIII tubulin.
    Joe PA; Banerjee A; Ludueña RF
    Cell Motil Cytoskeleton; 2008 Jun; 65(6):476-86. PubMed ID: 18435451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Termination of Protofilament Elongation by Eribulin Induces Lattice Defects that Promote Microtubule Catastrophes.
    Doodhi H; Prota AE; Rodríguez-García R; Xiao H; Custar DW; Bargsten K; Katrukha EA; Hilbert M; Hua S; Jiang K; Grigoriev I; Yang CH; Cox D; Horwitz SB; Kapitein LC; Akhmanova A; Steinmetz MO
    Curr Biol; 2016 Jul; 26(13):1713-1721. PubMed ID: 27321995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability.
    Kamath K; Wilson L; Cabral F; Jordan MA
    J Biol Chem; 2005 Apr; 280(13):12902-7. PubMed ID: 15695826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of tubulin drug binding sites and prediction of relative differences in binding affinities to tubulin isotypes using digital signal processing.
    Chen K; Huzil JT; Freedman H; Ramachandran P; Antoniou A; Tuszynski JA; Kurgan L
    J Mol Graph Model; 2008 Nov; 27(4):497-505. PubMed ID: 18951052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eribulin targets a ch-TOG-dependent directed migration of cancer cells.
    Chanez B; Gonçalves A; Badache A; Verdier-Pinard P
    Oncotarget; 2015 Dec; 6(39):41667-78. PubMed ID: 26497677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microtubulin binding sites as target for developing anticancer agents.
    Islam MN; Iskander MN
    Mini Rev Med Chem; 2004 Dec; 4(10):1077-104. PubMed ID: 15579115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.